[Macrocellular reticulum cell sarcoma as late clinical stage of an endoxan-treated Waldenström's macroglobulinemia].
D000368:Aged; D003520:Cyclophosphamide / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007668:Kidney / Q000473:pathology; D007680:Kidney Neoplasms / Q000209:etiology* / Q000473:pathology; D008099:Liver / Q000473:pathology; D008113:Liver Neoplasms / Q000209:etiology* / Q000473:pathology; D008168:Lung / Q000473:pathology; D008175:Lung Neoplasms / Q000209:etiology* / Q000473:pathology; D008198:Lymph Nodes / Q000473:pathology; D008207:Lymphatic Metastasis; D008228:Lymphoma, Non-Hodgkin / Q000209:etiology* / Q000473:pathology; D008297:Male; D008258:Waldenstrom Macroglobulinemia / Q000150:complications* / Q000188:drug therapy
D003520:Cyclophosphamide
Grosszelliges Retikulumzellsarkom als Spätzustand einer endoxanbehandelten Makroglobulinämie Waldenström.